Overview

Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Single-centre, open-label, randomised, gender-balanced, 3-way crossover, 3-period, 3-sequence study in 18 healthy male and female subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Eslicarbazepine acetate